Intravenous magnesium re-establishes neuromuscular block after spontaneous recovery from an intubating dose of rocuronium: A randomised controlled trial

European Journal of Anaesthesiology

Volumn 29, Issue 2, 2012, Pages 95-99

  Hans, Grégory A ^a   Bosenge, Besongo ^a   Bonhomme, Vincent L ^b   Brichant, Jean F ^a   Venneman, Ingrid M ^a   Hans, Pol C ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Centre Hospitalier Regional de La Citadelle   (Belgium)

Author keywords

Anaesthesia; Magnesium; Neuromuscular block; Rocuronium

Indexed keywords

MAGNESIUM; PLACEBO; ROCURONIUM; SODIUM CHLORIDE;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTUBATION; MALE; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANDROSTANOLS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTUBATION, INTRATRACHEAL; MAGNESIUM SULFATE; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84859736467     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32834e13a6     Document Type: Article

References (19)

1. Herroeder S, Schönherr ME, De Hert SG, Hollmann MW Magnesium: Essentials for anesthesiologists Anesthesiology 2011 114 971-993.
2. Fawcett W, Haxby E, Male D. Magnesium: Physiology and pharmacology. Br J Anaesth 1999; 83:302-320. (Pubitemid 29361145)
3. Fuchs-Buder T, Tassonyi E. Magnesium sulphate enhances residual neuromuscular block induced by vecuronium. Br J Anaesth 1996; 76:565-566.
4. Fawcett W, Stone J. Recurarization in the recovery room following the use of magnesium sulphate. Br J Anaesth 2003; 91:435-438. (Pubitemid 37063366)
5. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol. Anesthesiology 1998; 5:1170-1182. (Pubitemid 28216859)
6. Minto CF, Schnider TW, Egan TD, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. Anesthesiology 1997; 1:10-23. (Pubitemid 27043998)
7. Eikermann M, Groeben H, Bünten B, Peters J. Fade of pulmonary function during residual neuromuscular blockade. Chest 2005; 127:1703-1709. (Pubitemid 46218798)
8. Herbstreit F, Peters J, Eikermann M. Impaired upper airway integrity by residual neuromuscular blockade: Increased airway collapsibility and blunted genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2009; 110:1253-1260.
9. Murphy GS, Szokol JW, Marymont JH, et al. Residual neuromuscular blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 107:130-137.
10. Jenkinson D. The nature of the antagonism between calcium and magnesium ions at the neuromuscular junction. J Physiol 1957; 138:434-444.
11. Del Castillo J, Engbaek L. The nature of the neuromuscular block produced by magnesium. J Physiol 1954; 124:370-384.
12. Waud B, Waud D. The relation between the response to 'train-of-four' stimulation and receptor occlusion during competitive neuromuscular block. Anesthesiology 1972; 37:413-416.
13. Fuchs-Buder T, Ziegenfuss T, Lysakowski K, Tassonyi E. Antagonism of vecuronium-induced neuromuscular block in patients pretreated with magnesium sulphate: Dose-effect relationship of neostigmine. Br J Anaesth 1999; 82:61-65. (Pubitemid 29043130)
14. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808. (Pubitemid 47063004)
15. Motamed C, Kirov K, Combes X, Duvaldestin P. Comparison between the Datex-Ohmeda M-NMT module and a force-displacement transducer for monitoring neuromuscular blockade. Eur J Anaesthesiol 2003; 20:467-469. (Pubitemid 36648171)
16. Trager G, Michaud G, Deschamps S, Hemmerling TM. Comparison of phonomyography, kinemyography and mechanomyography for neuromuscular monitoring. Can J Anaesth 2006; 53:130-135.
17. Dahaba AA, von Klobucar F, Rehak PH, List WF. The neuromuscular transmission module versus the relaxometer mechanomyograph for neuromuscular block monitoring. Anesth Analg 2002; 94:591-596. (Pubitemid 34177555)
18. Isaka T, Suzuki T, Mizutani H, et al. Optimum intubating dose of rocuronium for short duration surgery in adult patients. Masui 2010; 59:160-163.
19. Sparr HJ, Beaufort TM, Fuchs-Buder T. Newer neuromuscular blocking agents: How do they compare with established agents? Drugs 2001; 61:919-942. (Pubitemid 32575394)